Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open Phase IV Study of Rapid Immunization Schedule with FSME-IMMUN 0.25 ml Junior in Children 1 to <15 Years
2010-020097-42Phase 4Terminated
- Sponsor
- Baxter International Inc.
- Start
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tick-borne encephalitis vaccine (inactivated) in tick-borne encephalitis (TBE), sponsored by Baxter International Inc. Primary endpoint: Seropositivity rate by neutralization test after second vaccination. Started Jun 2010; status: terminated.
02
Drugs
tick-borne encephalitis vaccine (inactivated)
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2010-020097-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020097-42.